Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

ACOG Alpha Cognition Inc

6,55

0,28 (4,47%)

24 Jan 2025 - Fermé

Retardé de 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

0001213900-25-002277.txt

Alpha Cognition (NASDAQ:ACOG)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Alpha Cognition

Alpha Cognition (NASDAQ:ACOG)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Alpha Cognition

Actualités Alpha Cognition Inc

OTC Markets Group Announces Quarterly Index Performance and Rebalancing
Mercredi 22 Janvier 2025 ( il y a 4 jours) • GlobeNewswire Inc.

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL
Mardi 14 Janvier 2025 ( il y a 2 semaines) • Business Wire

Form POS AM - Post-Effective amendments for registration statement
Vendredi 10 Janvier 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Vendredi 10 Janvier 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer’s Disease, in China
Mercredi 8 Janvier 2025 ( il y a 3 semaines) • Business Wire

Alpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer’s Long-Term Care Market During Investor Update Call
Lundi 6 Janvier 2025 ( il y a 3 semaines) • Business Wire

Alpha Cognition Announces Partial Exercise of Over-allotment Option
Lundi 16 Décembre 2024 ( il y a 1 mois) • Business Wire

Alpha Cognition Announces Voluntary Delisting from CSE
Vendredi 13 Décembre 2024 ( il y a 1 mois) • Business Wire

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
Mercredi 11 Décembre 2024 ( il y a 2 mois) • Business Wire

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update
Vendredi 15 Novembre 2024 ( il y a 2 mois) • Business Wire

Alpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq Listing
Mardi 12 Novembre 2024 ( il y a 2 mois) • Business Wire

Plus d'articles sur Alpha Cognition Inc

Lvmh Moet Hennessy Louis...

Societe Generale

Credit Agricole

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales